According to Lyell Immunopharma's latest financial reports the company's total assets are $0.75 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.75 B | -20% |
2022-12-31 | $0.93 B | -16.84% |
2021-12-31 | $1.12 B | 24.13% |
2020-12-31 | $0.90 B | 63.47% |
2019-12-31 | $0.55 B |